Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Wnt signaling pathway in bipolar disorder.

Todd D Gould, Husseini K Manji

    The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
    |October 11, 2002
    PubMed
    Summary

    The Wnt signaling pathway, including glycogen synthase kinase 3beta (GSK-3beta), is crucial for brain function and bipolar disorder treatment. Mood stabilizers like lithium affect this pathway, suggesting therapeutic potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology.

    Journal of psychopharmacology (Oxford, England)·2026
    Same author

    Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.

    Nature reviews. Drug discovery·2026
    Same author

    The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review.

    JAMA psychiatry·2026
    Same author

    A Time-Sensitive Plasticity Distinguishes the Rapid and Sustained Synaptic Actions of Ketamine from Its (2<i>R</i>,6<i>R</i>)-Hydroxynorketamine Metabolite.

    The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
    Same author

    Implementing Precision Medicine in Psychiatry.

    JAMA psychiatry·2025
    Same author

    Artificial intelligence and the acceleration of Alzheimer's research - From promise to practice.

    The journal of prevention of Alzheimer's disease·2025

    Area of Science:

    • Neuroscience
    • Molecular Biology
    • Pharmacology

    Background:

    • The Wnt signaling pathway is essential for embryonic development.
    • Emerging evidence links this pathway and GSK-3beta to synaptic plasticity, cell survival, and circadian rhythms in the mature central nervous system (CNS).
    • These CNS functions are implicated in the pathophysiology and treatment of bipolar disorder.

    Purpose of the Study:

    • To review the modulation of the Wnt/GSK-3beta signaling pathway by mood-stabilizing agents.
    • To focus on the therapeutically relevant aspects of neuroprotection and circadian rhythm modulation in bipolar disorder.
    • To explore the potential of targeting the Wnt pathway for treating bipolar disorder and neurodegenerative diseases.

    Main Methods:

    • Literature review of studies investigating the Wnt signaling pathway and its components.
    • Analysis of the effects of mood-stabilizing medications (lithium, valproic acid) on the Wnt pathway.
    • Examination of research linking Wnt signaling to neuroprotection and circadian rhythms.

    Main Results:

    • Mood stabilizers like lithium and valproic acid impact components of the Wnt signaling pathway.
    • The Wnt/GSK-3beta pathway is involved in neuroprotection and circadian rhythm regulation.
    • These findings suggest a significant role for the Wnt pathway in the treatment of bipolar disorder.

    Conclusions:

    • The Wnt signaling pathway, particularly GSK-3beta, is a promising target for bipolar disorder treatment.
    • Modulation of this pathway by existing mood stabilizers highlights its therapeutic relevance.
    • Selective GSK-3beta inhibitors could offer new treatment avenues for bipolar disorder and neurodegenerative conditions.

    Related Experiment Videos